News

Case Study: ICU-Based Chemotherapy for High-Risk Cardiac DLBCL Patient

A 34-year-old woman with newly diagnosed mediastinal diffuse large B-cell lymphoma developed alarming cardiac symptoms during her initial hospitalization.

News

Temple Lung Center | Enrolling Clinical Trials

The Temple Lung Center conducts one of the most comprehensive lung disease clinical trials programs in the country. Our advancements in basic, translational and clinical research are changing lung disease treatment. By pioneering effective ...

News

Temple Sets New National Record in Lung Transplant

The Temple Lung Center is one of the most active and experienced lung transplant programs in the world - and a national destination for complex, high-risk patients.

News

2026 GOLD Report: A Landmark Revision Shaping the Future of COPD Management

The Temple Lung Center continues to play a defining role in advancing the global standard of care for patients with chronic obstructive pulmonary disease (COPD). As a contributor to the international dialogue on evidence-based best practices, ...

News

EMR-Integrated Tool Identifies PAH Candidates Missed by Standard Referral Pathways

Pulmonary arterial hypertension is a life-threatening form of right heart failure, with poor survival when treatment is delayed. Unfortunately, because PAH has vague symptoms like shortness of breath and requires invasive testing, it typically ...

News

Temple Lung Center Performs First U.S. BREATHE-3 Procedure for Severe Emphysema

The Phase-3 trial of Apreo Health’s bronchoscopic airway scaffold for severe emphysema and hyperinflation is now enrolling at the Temple Lung Center.